However, NLRP3-caspase-1 inflammasome activation by other damage-associated molecular patterns released in the context of AD will trigger deleterious inflammation, hence the observations that caspase-1 inhibition ameliorates AD. This evidence concerns the gene CASP1 and Alzheimer disease.